Addressing Prescription Drug Abuse Requires Focus

more+
less-

Improving the prescribing and use of pain relievers – all prescription drugs, in fact – is a necessity. It should rest in the hands of those with authority and experience on the matter: medical and pharmacy boards, professional societies, and patient advocacy organizations, among others. The FDA, in focusing its efforts on these matters, is being distracted from its core responsibilities: expediting the development of innovative medicines, and evaluating them with urgency to meet public health needs. If the FDA focuses its attention on making safer medications available to prescribers, it can make a real difference in the lives of patients with dire medical needs and, indeed, all of us affected by prescription drug abuse.

LOADING PDF: If there are any problems, click here to download the file.

Written by:

Published In:

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Michael Barnes, DCBA Law & Policy | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »

All the intelligence you need, in one easy email:

Great! Your first step to building an email digest of JD Supra authors and topics. Log in with LinkedIn so we can start sending your digest...

Sign up for your custom alerts now, using LinkedIn ›

* With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name.
×
Loading...
×
×